Mauna Kea Technologies SAS (PA:ALMKT) — Market Cap & Net Worth
Market Cap & Net Worth: Mauna Kea Technologies SAS (ALMKT)
Mauna Kea Technologies SAS (PA:ALMKT) has a market capitalization of $28.43 Million (€24.32 Million) as of August 6, 2026. Listed on the PA stock exchange, this France-based company holds position #23917 globally and #382 in its home market, demonstrating a 3.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mauna Kea Technologies SAS's stock price €0.16 by its total outstanding shares 192097275 (192.10 Million). See Mauna Kea Technologies SAS (ALMKT) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Mauna Kea Technologies SAS Market Cap History: 2015 to 2026
Mauna Kea Technologies SAS's market capitalization history from 2015 to 2026. Data shows change from $689.47 Million to $34.81 Million (-22.70% CAGR).
Mauna Kea Technologies SAS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mauna Kea Technologies SAS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.93x
Mauna Kea Technologies SAS's market cap is 4.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $689.47 Million | $8.55 Million | -$12.64 Million | 80.67x | N/A |
| 2016 | $678.24 Million | $8.79 Million | -$9.74 Million | 77.19x | N/A |
| 2017 | $1.06 Billion | $6.69 Million | -$10.24 Million | 159.19x | N/A |
| 2018 | $451.41 Million | $6.76 Million | -$13.22 Million | 66.78x | N/A |
| 2019 | $306.78 Million | $8.51 Million | -$15.27 Million | 36.05x | N/A |
| 2020 | $295.55 Million | $6.53 Million | -$12.79 Million | 45.29x | N/A |
| 2021 | $171.81 Million | $7.70 Million | -$13.45 Million | 22.31x | N/A |
| 2022 | $93.20 Million | $7.48 Million | -$11.18 Million | 12.46x | N/A |
| 2023 | $105.78 Million | $11.03 Million | -$3.73 Million | 9.59x | N/A |
| 2024 | $37.73 Million | $7.66 Million | -$10.40 Million | 4.93x | N/A |
Competitor Companies of ALMKT by Market Capitalization
Companies near Mauna Kea Technologies SAS in the global market cap rankings as of August 6, 2026.
Key companies related to Mauna Kea Technologies SAS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #118 globally with a market cap of $183.38 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #184 globally with a market cap of $128.57 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #232 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #241 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #118 | Abbott Laboratories | NYSE:ABT | $183.38 Billion | $105.46 |
| #184 | Stryker Corporation | NYSE:SYK | $128.57 Billion | $335.96 |
| #232 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #241 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $86.20 |
Mauna Kea Technologies SAS Historical Marketcap From 2015 to 2026
Between 2015 and today, Mauna Kea Technologies SAS's market cap moved from $689.47 Million to $ 34.81 Million, with a yearly change of -22.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €34.81 Million | +112.04% |
| 2025 | €16.42 Million | -56.49% |
| 2024 | €37.73 Million | -64.33% |
| 2023 | €105.78 Million | +13.49% |
| 2022 | €93.20 Million | -45.75% |
| 2021 | €171.81 Million | -41.87% |
| 2020 | €295.55 Million | -3.66% |
| 2019 | €306.78 Million | -32.04% |
| 2018 | €451.41 Million | -57.59% |
| 2017 | €1.06 Billion | +56.95% |
| 2016 | €678.24 Million | -1.63% |
| 2015 | €689.47 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 5th, 2026 the market cap of Mauna Kea Technologies SAS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.43 Million USD |
| MoneyControl | $28.43 Million USD |
| MarketWatch | $28.43 Million USD |
| marketcap.company | $28.43 Million USD |
| Reuters | $28.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more